| Product Name | Tafazzin |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TAZ antibody; EFE2 antibody; G4.5 antibody; Tafazzin antibody; Protein G4.5 antibody; |
| Product description | This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. |
| Immunogen | Synthesized peptide derived from the Internal region of human Tafazzin. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500-1:2000 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | TAZ antibody EFE2 antibody G4.5 antibody Tafazzin antibody Protein G4.5 antibody |
|---|---|
| Molecular Weight(MW) | 33 kDa |
| SwissProt ID | Q16635 |
|---|
| Positive Control | Heart,Lymph,Skeletal muscle, |
|---|---|
| Application Notes | WB:1:500-1:2000 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
